Genetic analysis of mucopolysaccharidosis type VI in Taiwanese patients.

[1]  D. Brooks,et al.  Mutational analysis of 105 mucopolysaccharidosis type VI patients , 2007, Human mutation.

[2]  B. Cormand,et al.  Identification of the molecular defects in Spanish and Argentinian mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) patients, including 9 novel mutations. , 2007, Molecular genetics and metabolism.

[3]  D. Brooks,et al.  Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapy. , 2004, Molecular Genetics and Metabolism.

[4]  J. Chen,et al.  Two novel mutations of the arylsulfatase B gene in a Chinese MPS VI child undergoing bone marrow transplantation therapy. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[5]  J. Wittes,et al.  Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. , 2006, The Journal of pediatrics.

[6]  R. Giugliani,et al.  Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulphatase B gene in South American patients , 2005, Journal of Inherited Metabolic Disease.

[7]  D. Brooks,et al.  An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum. , 2005, Molecular genetics and metabolism.

[8]  C. Lam,et al.  A novel mutation, Y255X, of the ARSB gene in a Chinese family with mucopolysaccharidosis type VI. , 2004, Chinese medical journal.

[9]  P. Kaplan,et al.  Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). , 2004, The Journal of pediatrics.

[10]  C. Hall,et al.  Bone marrow transplantation for Maroteaux–Lamy syndrome (MPS VI): Long-term follow-up , 1999, Journal of Inherited Metabolic Disease.

[11]  W. Krivit.  Stem cell bone marrow transplantation in patients with metabolic storage diseases. , 2002, Advances in pediatrics.

[12]  F. Tsai,et al.  Mucopolysaccharidosis type VI: Report of two Taiwanese patients and identification of one novel mutation. , 2001, Journal of the Formosan Medical Association = Taiwan yi zhi.

[13]  J. Hopwood,et al.  Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N‐acetylgalactosamine‐4‐sulfatase , 2001, Human mutation.

[14]  D Baker,et al.  Mechanisms of protein folding. , 2001, Current opinion in structural biology.

[15]  K. von Figura,et al.  [Identification of mutations in the arylsulfatase B gene in Russian mucopolysaccharidosis type VI patients]. , 2000, Genetika.

[16]  F. Tsai,et al.  A novel mutation (Q239R) identified in a Taiwan Chinese patient with type VI mucopolysaccharidosis (Maroteaux‐Lamy syndrome) , 2000, Human mutation.

[17]  G. Lukatela,et al.  Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis. , 1998, Biochemistry.

[18]  C. Bond,et al.  Structure of a human lysosomal sulfatase. , 1997, Structure.

[19]  T. Selmer,et al.  A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency , 1995, Cell.

[20]  A. Ballabio,et al.  A cluster of sulfatase genes on Xp22.3: Mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy , 1995, Cell.

[21]  C. Peters,et al.  Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): six unique arylsulfatase B gene alleles causing variable disease phenotypes. , 1994, American journal of human genetics.

[22]  C. Peters,et al.  Structure of the human arylsulfatase B gene. , 1993, Biological chemistry Hoppe-Seyler.

[23]  C. Peters,et al.  Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B. , 1990, The Journal of biological chemistry.

[24]  R. Desnick,et al.  Human arylsulfatase B: MOPAC cloning, nucleotide sequence of a full-length cDNA, and regions of amino acid identity with arylsulfatases A and C. , 1990, Genomics.

[25]  M. Rodo,et al.  [Further steps in regional localization of the gene coding for human arylsulfatase B (ARSB): gene assignment to the section q11-qter of chromosome 5]. , 1990, Problemy medycyny wieku rozwojowego.

[26]  D. Brooks,et al.  Human N-acetylgalactosamine-4-sulphate sulphatase. Purification, monoclonal antibody production and native and subunit Mr values. , 1987, The Biochemical journal.

[27]  S. Wald,et al.  Compressive myelopathy associated with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). , 1984, Neurosurgery.

[28]  P. Chang,et al.  Differential assay of arylsulfatase A and B activities: a sensitive method for cultured human cells. , 1981, Analytical biochemistry.

[29]  R. Desnick,et al.  An improved method for heterozygote identification in feline and human mucopolysaccharidosis VI, arylsulfatase-B deficiency. , 1981, Enzyme.

[30]  H. Quigley,et al.  Ultrastructural and histochemical studies of a newly recognized form of systemic mucopolysaccharidosis. (Maroteaux-Lamy syndrome, mild phenotype). , 1974, American journal of ophthalmology.